NOGRA

Serial Number 98529417
Registration 7678164
700

Registration Progress

Application Filed
May 1, 2024
Under Examination
Approved for Publication
Dec 17, 2024
Published for Opposition
Dec 17, 2024
Registered
Feb 4, 2025

Basic Information

Serial Number
98529417
Registration Number
7678164
Filing Date
May 1, 2024
Registration Date
February 4, 2025
Published for Opposition
December 17, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 4, 2025
Registration
Registered
Classes
005

Rights Holder

Nogra Pharma Limited

99
Address
33 Sir John Rogerson's Quay
Dublin 2 D02XK09
IE

Ownership History

Nogra Pharma Limited

Original Applicant
99
Dublin 2 IE

Nogra Pharma Limited

Owner at Publication
99
Dublin 2 IE

Nogra Pharma Limited

Original Registrant
99
Dublin 2 IE

Legal Representation

Attorney
Amy C. Ziegler

USPTO Deadlines

Next Deadline
2037 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-04)
Due Date
February 04, 2031
Grace Period Ends
August 04, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

17 events
Date Code Type Description
Feb 4, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 4, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 17, 2024 PUBO A PUBLISHED FOR OPPOSITION
Dec 11, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN
Nov 19, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED
Nov 19, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED
Nov 19, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 15, 2024 DOCK D ASSIGNED TO EXAMINER
Sep 24, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 24, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 24, 2024 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 24, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 1, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of immune system related diseases and disorders and inflammatory disorders, gastrointestinal diseases and disorders and skin disorders

Classification

International Classes
005